Tidmarsh announces, then retracts, surrogate endpoint review George Tidmarsh, Director of CDER, posted that while surrogate endpoints have accelerated treatments, they also risk failures in confirmatory trials
avoid vigorous shaking Do NOT freeze after reconstitution Inspect solution before use: should be clear, colorless, and free of particulates Discard if cloudy, discolored, or precipitated Use sterile techniques during reconstitution and experimental handling Protect from heat, light, and mechanical agitation to preserve peptide integrity Retatrutide is most stable as a lyophilized powder stored refrigerated or frozen
In theory, changes in protein accessibility to solvents can be determined by computing the solvent-accessible surface area (SASA)
They contribute to the growth and preservation of cells in the pancreas, which are responsible for insulin production